IRCT20111206008307N42已完成3 期
Empagliflozin effects in patients with ST-elevation myocardial infarction undergoing primary PCI: a randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients with STEMI undergoing primary PCI
- •Patients aged between 18 to 80 years
- •Consented patients
排除标准
- •Renal failure (eGFR < 30)
- •Hepatic failure
- •Systolic blood pressure less than 100 mmHg
- •Inflammatory and autoimmune diseases
- •Diabetes mellitus
- •Chronic heart failure
- •Psychiatric disorders
- •Empagliflozin contraindications
- •History of receiving empagliflozin
- •History of myocardial infarction
- •Arrival more than 6 hours from symptoms onset
研究者
相似试验
尚未招募
不适用
Clinical effects of empagliflozin dose increase in patients with type 2 diabetes: a retrospective observational studyType 2 diabetesJPRN-UMIN000041543Department of Metabolic Medicine, Nishinihon Hospital100
已完成
3 期
Dapagliflozin effects in patients with myocardial infarctioMyocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20111206008307N44Tabriz University of Medical Sciences100
进行中（未招募）
1 期
SGLT2 inhibition with empagliflozin in patients with type 2 diabetes mellitus: Influences on left ventricular mass, function, and lipid content of myocardium (EMPATROPHY)Patients with type 2 diabetes mellitus on background metformin treatment.MedDRA version: 18.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-003313-28-DEHannover Medical School60
已完成
1 期
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30
尚未招募
2 期
Assessment of extra-renal effects of SGLT2-inhibitors in anuric haemodialysis patients using microneurographyEnd Stage Kidney Disease (ESKD) with AnuriaRenal and Urogenital - Kidney diseaseACTRN12623001237673Dobney Hypertension Centre20